Exosomes
Nature’s Nanocarriers: The Evolving Role of Exosomes in Targeted Drug Delivery
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-25-NI-04May 13, 2025
Protein Portfolio
Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine
Bio-Techne Corporation
PR-01-25-NI-05Jan 10, 2025
Bone Regeneration
A Novel Technology Platform for Bone Regeneration and Cancer Treatment
Denis Dufrane, M.D., Ph.D.
PAO-03-23-CL-06Mar 20, 2023
Regenerative Medicine
NFTs Are Bringing the Regenerative Medicine Community Together
Danielle Alvarez
Pharma's Almanac
PAO-05-022-CL-07May 23, 2022
Regenerative Medicine
Eliminating Immunosuppression in Regenerative Medicine
iTolerance
PAO-04-22-R250-74Apr 29, 2022
Ischemia
Battling Ischemia with Therapeutic Angiogenesis
Zhittya Genesis Medicine
PAO-03-22-R250-11Mar 15, 2022
Regenerative Medicine
Accelerating Innovation in Regenerative Medicine
RoosterBio
PAO-02-22-R250-04Feb 03, 2022
Cell Therapy
Enabling Novel Cell Therapies by Leveraging Established Blood Stem Cell Transplant Infrastructure
Chris McClain
Be The Match BioTherapies
PAO-09-21-CL-04Sep 09, 2021
Clinical Trials
Krystal Biotech Announces Positive Results from Phase 2 Clinical Trial and Receives Regenerative Medicine Advanced Therapy Designation
Krystal Biotech
PR-M06-19-NI-047Jun 25, 2019
Stem Cell Therapy
Exploring the Efficacy of Stem Cells in Reversing Age-Related Frailty
Geoff Green
Longeveron
PAP-Q2-2019-CL-023May 24, 2019
FDA
FDA Advances New Efforts to Promote Development of Safe and Effective Regenerative Medicine Products
U.S. Food & Drug Administration
PR-M02-19-NI-037Feb 19, 2019
Regenerative Medicine Therapies
Affordable Regenerative Stem Cell Therapy is Now Offered Through Zen Care Physical Medicine in Irvine at an Extraordinary Value
Zen Care
PR-M08-18-NI-094Aug 23, 2018
Regenerative Medicine Therapies
Ambys Medicines Launches with $140 Million to Pioneer Regenerative Medicine Therapies for Serious Liver Diseases
Cytotheryx
PR-M08-18-NI-079Aug 20, 2018
Regenerative Medicine
International Society for Cellular Therapy Supports New FDA Policy Framework for Regenerative Medicine
Emilie Branch
Pharma's Almanac
PAO-M12-17-NI-004Dec 01, 2017